ICUI (STOCKS)
ICU Medical Inc
$147.730000
-5.490000 (-3.58%)
Prev close: $153.220000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Vivek Jain
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,645.48M
- Employees
- 15,000
- P/E (TTM)
- -475.17
- P/B (TTM)
- 1.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$2.03 | $1.46 | +0.5680 | +38.85% |
|
Jun 2025 (Q2)
|
$2.10 | $1.53 | +0.5700 | +37.25% |
|
Mar 2025 (Q1)
|
$1.72 | $1.31 | +0.4144 | +31.74% |
|
Dec 2024 (Q4)
|
$2.11 | $1.51 | +0.5984 | +39.59% |
Financial Statements
| Revenues | $2.32B |
| Benefits Costs and Expenses | -$156.17M |
| Cost Of Revenue | $1.47B |
| Costs And Expenses | $2.18B |
| Gross Profit | $846.31M |
| Nonoperating Income/Loss | -$5.36M |
| Operating Expenses | $771.43M |
| Selling, General, and Administrative Expenses | $628.25M |
| Research and Development | $88.76M |
| Other Operating Expenses | $54.42M |
| Operating Income/Loss | $74.89M |
| Income/Loss From Continuing Operations After Tax | -$5.82M |
| Income/Loss From Continuing Operations Before Tax | $2.48B |
| Income Tax Expense/Benefit | $37.14M |
| Interest Expense, Operating | $96.63M |
| Net Income/Loss | -$7.36M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.36M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.36M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.31 |
| Diluted Earnings Per Share | -$0.32 |
| Basic Average Shares | 24,659,000 |
| Diluted Average Shares | 24,818,000 |
| Assets | $4.10B |
| Current Assets | $1.21B |
| Inventory | $622.44M |
| Other Current Assets | $584.85M |
| Noncurrent Assets | $2.90B |
| Fixed Assets | $455.97M |
| Intangible Assets | $664.83M |
| Other Non-current Assets | $1.77B |
| Liabilities | $1.98B |
| Current Liabilities | $492.90M |
| Accounts Payable | $171.75M |
| Other Current Liabilities | $321.15M |
| Noncurrent Liabilities | $1.48B |
| Equity | $2.13B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.13B |
| Liabilities And Equity | $4.10B |
| Net Cash Flow From Operating Activities | $159.44M |
| Net Cash Flow From Operating Activities, Continuing | $159.44M |
| Net Cash Flow From Investing Activities | $114.07M |
| Net Cash Flow From Investing Activities, Continuing | $114.07M |
| Net Cash Flow From Financing Activities | -$285.23M |
| Net Cash Flow From Financing Activities, Continuing | -$285.23M |
| Exchange Gains/Losses | -$1.06M |
| Net Cash Flow | -$12.78M |
| Net Cash Flow, Continuing | -$11.72M |
| Comprehensive Income/Loss | $22.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $22.10M |
| Other Comprehensive Income/Loss | $29.46M |